D
Nektar Therapeutics NKTR
$0.8968 $0.08149.98%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 93.14M 93.16M 90.17M 90.12M 88.26M
Total Other Revenue -- -- -- -- --
Total Revenue 93.14M 93.16M 90.17M 90.12M 88.26M
Cost of Revenue 29.99M 37.99M 35.24M 33.77M 32.72M
Gross Profit 63.15M 55.17M 54.93M 56.35M 55.54M
SG&A Expenses 76.94M 79.13M 76.49M 77.42M 82.04M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 229.03M 228.26M 222.83M 225.35M 233.71M
Operating Income -135.90M -135.10M -132.66M -135.23M -145.45M
Income Before Tax -168.31M -177.16M -176.01M -276.26M -290.69M
Income Tax Expenses -9.00K -79.00K -172.00K -200.00K 2.97M
Earnings from Continuing Operations -168.30 -177.08 -175.84 -276.06 -293.67
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -168.30M -177.08M -175.84M -276.06M -293.67M
EBIT -135.90M -135.10M -132.66M -135.23M -145.45M
EBITDA -130.19M -128.69M -125.54M -127.41M -136.11M
EPS Basic -0.84 -0.90 -0.92 -1.46 -1.55
Normalized Basic EPS -0.45 -0.46 -0.45 -0.47 -0.51
EPS Diluted -0.84 -0.90 -0.92 -1.46 -1.56
Normalized Diluted EPS -0.45 -0.46 -0.45 -0.47 -0.51
Average Basic Shares Outstanding 803.86M 785.02M 765.85M 759.98M 757.17M
Average Diluted Shares Outstanding 803.86M 785.02M 765.85M 759.98M 757.17M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings